BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 83592)

  • 1. Distribution of beta2-microglobulin in cerebrospinal fluid and in cystic fluid of brain tumors. A preliminary study.
    Schaub C; Bluet-Pajot MT; Szikla G; Lornet-Videau C; Mounier F; Talairach J
    Pathol Biol (Paris); 1978 Sep; 26(6):381-5. PubMed ID: 83592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [beta2-Microglobulin determination's estimation in cerebrospinal fluid (author's transl)].
    Lavocat C; Merienne L; Ziegler M; Fauchier P; Riche F; Askienazy S
    Pathol Biol (Paris); 1978 Sep; 26(6):387-9. PubMed ID: 83593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elevated cerebrospinal fluid beta-2 microglobulin as a tumor marker in a patient with myeloma of the central nervous system.
    Alsobhi EM; Hashim IA; Abdelaal MA; Aljifri AM; Alshamy AM
    Saudi Med J; 2007 Jan; 28(1):128-30. PubMed ID: 17206305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Beta 2-microglobulin and tumors of the central nervous system].
    Hrazdirová V; Hrazdira CL; Polcáková M
    Cesk Neurol Neurochir; 1990 Jan; 53(1):17-21. PubMed ID: 2185897
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytopathology of cerebrospinal fluid. II. Metastatic cancer, meningeal carcinomatosis and primary central nervous system neoplasms.
    Bigner SH; Johnston WW
    Acta Cytol; 1981; 25(5):461-79. PubMed ID: 7025541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebrospinal fluid beta-2-microglobulin level as marker of central nervous system involvement in lymphoma.
    Pagano L; Marra R; Storti S; De Stefano V; Bizzi B
    Haematologia (Budap); 1986; 19(2):121-5. PubMed ID: 3530906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical significance of beta 2-microglobulin and carcinoembryonic antigen in intracranial tumors].
    Suzuki Y; Ishii R; Otsuka R; Ogawa Y; Kikuoka M; Hirano K; Tanaka R
    No To Shinkei; 1987 Oct; 39(10):965-70. PubMed ID: 3325088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Comparison of the variations in the levels of beta2-microglobulin and carcino-embryonic antigen in the breast cancer and malignant melanoma (author's transl)].
    Grenier J; Serrou B; Suquet P; Pujol H
    Pathol Biol (Paris); 1978 Sep; 26(6):371-2. PubMed ID: 83589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [CSF levels and diagnostic utility of cerebrospinal fluid beta2-microglobulin].
    Caudie C; Bancel J; Dupont M; Matanza D; Poitevin F; Honnorat J
    Ann Biol Clin (Paris); 2005; 63(6):631-7. PubMed ID: 16330382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [beta2-Microglobulin in cancer patients (author's transl)].
    Daver A; Chassevent A; Bouali AB; Bertrand AF; Deroche C; Cellier P; Tuchais C; Souaille C; Maillart P; Bertrand G; Minier JF; Larra F; Agerup B
    Pathol Biol (Paris); 1978 Sep; 26(6):335-40. PubMed ID: 83577
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis of leukemia or lymphoma in the central nervous system by beta 2-microglobulin determination.
    Mavlight GM; Stuckey SE; Cabanillas FF; Keating MJ; Tourtellotte WW; Schold SC; Freireich EJ
    N Engl J Med; 1980 Sep; 303(13):718-22. PubMed ID: 6157089
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melanoma-inhibiting activity (MIA/CD-RAP) is expressed in a variety of malignant tumors of mainly neuroectodermal origin.
    Hau P; Apfel R; Wiese P; Tschertner I; Blesch A; Bogdahn U
    Anticancer Res; 2002; 22(2A):577-83. PubMed ID: 12014625
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of central nervous system metastasis with cerebrospinal fluid beta-2-microglobulin.
    Koch TR; Lichtenfeld KM; Wiernik PH
    Cancer; 1983 Jul; 52(1):101-4. PubMed ID: 6189578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Electrophoretic study of cerebrospinal fluid proteins in 104 cases of neuraxis tumors].
    Castaigne P; Lhermitte F; Schuller E; Perrin JJ; Delasnerie N
    Rev Neurol (Paris); 1972 Nov; 127(5):505-15. PubMed ID: 4129440
    [No Abstract]   [Full Text] [Related]  

  • 15. [Serum beta2-microglobulin and carcino-embryonic antigen in cancerous patients. A preliminary study of 258 cases (author's transl)].
    Pouillart P; Magdelenat H; Palangie T; Gongora R
    Pathol Biol (Paris); 1978 Sep; 26(6):363-5. PubMed ID: 83587
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid cytology in patients with brain tumors; a simple method using the cell culture technique.
    Kajikawa H; Ohta T; Ohshiro H; Harada K; Ishikawa S
    Acta Cytol; 1977; 21(1):162-7. PubMed ID: 264751
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [beta2-Microglobulin levels in cerebrospinal fluid--the levels in various neurological diseases and their comparison with those in serum (author's transl)].
    Adachi N; Tshukagoshi H; Murakami F; Kanai M
    Rinsho Shinkeigaku; 1978 Jun; 18(6):351-7. PubMed ID: 81117
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship of polyamines in cerebrospinal fluid to the presence of central nervous system tumors.
    Marton LJ; Heby O; Levin VA; Lubich WP; Crafts DC; Wilson CB
    Cancer Res; 1976 Mar; 36(3):973-7. PubMed ID: 1253185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevation of beta 2-microglobulin in cerebrospinal fluid after irradiation of the central nervous system.
    Demeocq F; Malpuech G; Raynaud EJ; Plagne R; Gaillard G
    N Engl J Med; 1981 May; 304(22):1366. PubMed ID: 6163986
    [No Abstract]   [Full Text] [Related]  

  • 20. [Occurrence of beta2-microglobulin in normal and carcinomatous renal tissue (author's transl)].
    Popelier G; Sion H
    Pathol Biol (Paris); 1978 Sep; 26(6):367-9. PubMed ID: 83588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.